These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 37279500)

  • 1. Cardiac-specific BACH1 ablation attenuates pathological cardiac hypertrophy by inhibiting the Ang II type 1 receptor expression and the Ca2+/CaMKII pathway.
    Wei X; Jin J; Wu J; He Y; Guo J; Yang Z; Chen L; Hu K; Li L; Jia M; Li Q; Lv X; Ge F; Ma S; Wu H; Zhi X; Wang X; Jiang L; Osto E; Zhang J; Meng D
    Cardiovasc Res; 2023 Aug; 119(9):1842-1855. PubMed ID: 37279500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca
    Xiao YF; Zeng ZX; Guan XH; Wang LF; Wang CJ; Shi H; Shou W; Deng KY; Xin HB
    J Cell Mol Med; 2018 Jul; 22(7):3638-3651. PubMed ID: 29682889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
    Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
    Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction.
    Ainscough JF; Drinkhill MJ; Sedo A; Turner NA; Brooke DA; Balmforth AJ; Ball SG
    Cardiovasc Res; 2009 Feb; 81(3):592-600. PubMed ID: 18703536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
    Yu L; Meng W; Ding J; Cheng M
    Biochem Biophys Res Commun; 2016 Apr; 473(2):455-61. PubMed ID: 26970306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sildenafil Does Not Prevent Heart Hypertrophy and Fibrosis Induced by Cardiomyocyte Angiotensin II Type 1 Receptor Signaling.
    Straubinger J; Schöttle V; Bork N; Subramanian H; Dünnes S; Russwurm M; Gawaz M; Friebe A; Nemer M; Nikolaev VO; Lukowski R
    J Pharmacol Exp Ther; 2015 Sep; 354(3):406-16. PubMed ID: 26157043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CaMKIIδC Drives Early Adaptive Ca
    Ljubojevic-Holzer S; Herren AW; Djalinac N; Voglhuber J; Morotti S; Holzer M; Wood BM; Abdellatif M; Matzer I; Sacherer M; Radulovic S; Wallner M; Ivanov M; Wagner S; Sossalla S; von Lewinski D; Pieske B; Brown JH; Sedej S; Bossuyt J; Bers DM
    Circ Res; 2020 Oct; 127(9):1159-1178. PubMed ID: 32821022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caveolin-3 Overexpression Attenuates Cardiac Hypertrophy via Inhibition of T-type Ca2+ Current Modulated by Protein Kinase Cα in Cardiomyocytes.
    Markandeya YS; Phelan LJ; Woon MT; Keefe AM; Reynolds CR; August BK; Hacker TA; Roth DM; Patel HH; Balijepalli RC
    J Biol Chem; 2015 Sep; 290(36):22085-100. PubMed ID: 26170457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of transient receptor potential vanilloid 4 is involved in pressure overload-induced cardiac hypertrophy.
    Zou Y; Zhang M; Wu Q; Zhao N; Chen M; Yang C; Du Y; Han B
    Elife; 2022 Jun; 11():. PubMed ID: 35731090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA TINCR attenuates cardiac hypertrophy by epigenetically silencing CaMKII.
    Shao M; Chen G; Lv F; Liu Y; Tian H; Tao R; Jiang R; Zhang W; Zhuo C
    Oncotarget; 2017 Jul; 8(29):47565-47573. PubMed ID: 28548932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarction.
    Singh MV; Swaminathan PD; Luczak ED; Kutschke W; Weiss RM; Anderson ME
    J Mol Cell Cardiol; 2012 May; 52(5):1135-44. PubMed ID: 22326848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca
    Baier MJ; Klatt S; Hammer KP; Maier LS; Rokita AG
    J Mol Cell Cardiol; 2020 Jan; 138():212-221. PubMed ID: 31836540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermedin alleviates pathological cardiac remodeling by upregulating klotho.
    Zhang LS; Liu Y; Chen Y; Ren JL; Zhang YR; Yu YR; Jia MZ; Ning ZP; Du J; Tang CS; Qi YF
    Pharmacol Res; 2020 Sep; 159():104926. PubMed ID: 32502636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of Interleukin-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and Dysfunction.
    Zhao L; Cheng G; Jin R; Afzal MR; Samanta A; Xuan YT; Girgis M; Elias HK; Zhu Y; Davani A; Yang Y; Chen X; Ye S; Wang OL; Chen L; Hauptman J; Vincent RJ; Dawn B
    Circ Res; 2016 Jun; 118(12):1918-1929. PubMed ID: 27126808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIRT4 accelerates Ang II-induced pathological cardiac hypertrophy by inhibiting manganese superoxide dismutase activity.
    Luo YX; Tang X; An XZ; Xie XM; Chen XF; Zhao X; Hao DL; Chen HZ; Liu DP
    Eur Heart J; 2017 May; 38(18):1389-1398. PubMed ID: 27099261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel peptide athycaltide-1 attenuates Ang II-induced pathological myocardial hypertrophy by reducing ROS and inhibiting the activation of CaMKII and ERK1/2.
    Zheng X; Su F; Lei M; Li J; Zhang C; Zhang Y; Wei M; Li W; Chen S; Liu Y; Gao Q; Hao L
    Eur J Pharmacol; 2023 Oct; 957():175969. PubMed ID: 37567457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type III Transforming Growth Factor-β Receptor Drives Cardiac Hypertrophy Through β-Arrestin2-Dependent Activation of Calmodulin-Dependent Protein Kinase II.
    Lou J; Zhao D; Zhang LL; Song SY; Li YC; Sun F; Ding XQ; Yu CJ; Li YY; Liu MT; Dong CJ; Ji Y; Li H; Chu W; Zhang ZR
    Hypertension; 2016 Sep; 68(3):654-66. PubMed ID: 27432858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II-induced oxidative stress resets the Ca2+ dependence of Ca2+-calmodulin protein kinase II and promotes a death pathway conserved across different species.
    Palomeque J; Rueda OV; Sapia L; Valverde CA; Salas M; Petroff MV; Mattiazzi A
    Circ Res; 2009 Dec; 105(12):1204-12. PubMed ID: 19850941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promyelocytic leukemia zinc finger protein activates GATA4 transcription and mediates cardiac hypertrophic signaling from angiotensin II receptor 2.
    Wang N; Frank GD; Ding R; Tan Z; Rachakonda A; Pandolfi PP; Senbonmatsu T; Landon EJ; Inagami T
    PLoS One; 2012; 7(4):e35632. PubMed ID: 22558183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIMF (Hypoxia-Induced Mitogenic Factor)-IL (Interleukin)-6 Signaling Mediates Cardiomyocyte-Fibroblast Crosstalk to Promote Cardiac Hypertrophy and Fibrosis.
    Kumar S; Wang G; Zheng N; Cheng W; Ouyang K; Lin H; Liao Y; Liu J
    Hypertension; 2019 May; 73(5):1058-1070. PubMed ID: 30827145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.